Table 1 Types of therapies patients received outside of their home country according to Mexican oncologists
Therapy type | US-based patients N = 59 | Mexico-based patients N = 49 |
|---|---|---|
Neoadjuvant chemotherapy | 29 (49.2%) | 23 (46.9%) |
Adjuvant chemotherapy | 31 (52.5%) | 24 (49.0%) |
Palliative chemotherapy | 25 (42.4%) | 24 (49.0%) |
Immunotherapy | 22 (37.3%) | 29 (59.2%) |
Hormonal therapy | 20 (22.9%) | 14 (28.6%) |
Autologous transplant | 3 (5.1%) | 6 (12.2%) |
Allogeneic transplant | 1 (1.7%) | 5 (10.2%) |
CAR-T cell therapy | 0 (0.0%) | 5 (10.2%) |
Curative surgery | 38 (64.4%) | 27 (55.1%) |
Palliative surgery | 19 (32.2%) | 11 (22.4%) |
Curative radiation | 22 (37.3%) | 16 (32.7%) |
Palliative radiation | 15 (25.4%) | 7 (14.3%) |
Non-approved therapies | 7 (11.9%) | 0 (0.0%) |
Symptom management | 16 (27.1%) | 9 (18.4%) |